Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 21 Jul 2025 for Blueprint Medicines Corp.
Filing timeline
BuySalePhilina Lee
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
Philina Lee: trading record in brief
Philina Lee is a declared insider of Blueprint Medicines Corp, with filings sourced from SEC (Form 4). We count 23 filings; the first trade dates from 1 March 2023 and the latest from 17 July 2025.
No open-market purchase appears, only 7 sales worth €4.9M. Outside the open market, there are 4 share grants and 10 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
The latest filing, published on 21 July 2025, reports a transaction in Blueprint Medicines Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Philina Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
21,353 sharesCommon StockSEC:0001104659-25-069378:0
3,733 shares@ US$88.8049.1% of flowCommon StockSEC:0001415889-25-007396:0
11,000 shares0Common StockSEC:0001415889-25-006609:0
157 shares@ US$36.050.8% of flowCommon StockSEC:0001415889-24-020928:0
523 shares@ US$8.800.7% of flowCommon StockSEC:0001415889-24-008124:0
2,934 shares@ US$90.6938.4% of flowCommon StockSEC:0001415889-24-007559:0
12,500 shares0Common StockSEC:0001415889-24-007024:0
261 shares@ US$1.870.1% of flowCommon StockSEC:0001415889-24-003825:0
1,622 shares@ US$45.7211.0% of flowCommon StockSEC:0001415889-23-004562:0
12,500 shares0Common StockSEC:0001415889-23-004267:0
10 of 10 declarations
